176 related articles for article (PubMed ID: 15794500)
1. Advances in the use of colony-stimulating factors for chemotherapy-induced neutropenia.
Dale DC
J Support Oncol; 2005; 3(2 Suppl 1):39-41. PubMed ID: 15794500
[No Abstract] [Full Text] [Related]
2. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
3. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
Heuser M; Ganser A; Bokemeyer C; ; ;
Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factors: finding the right indication.
Lyman GH; Shayne M
Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791
[TBL] [Abstract][Full Text] [Related]
5. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
[TBL] [Abstract][Full Text] [Related]
6. NCCN guidelines advocate wider use of colony-stimulating factor.
McNeil C
J Natl Cancer Inst; 2005 May; 97(10):710-1. PubMed ID: 15900037
[No Abstract] [Full Text] [Related]
7. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
[TBL] [Abstract][Full Text] [Related]
8. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
[No Abstract] [Full Text] [Related]
9. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
11. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
12. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
[TBL] [Abstract][Full Text] [Related]
13. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
14. The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia.
Lyman GH; Kuderer NM
Crit Rev Oncol Hematol; 2004 May; 50(2):129-46. PubMed ID: 15157662
[TBL] [Abstract][Full Text] [Related]
15. Pegfilgrastim: evidence in support of its use with cytotoxic chemotherapy.
Ng R; Green MD
Expert Rev Anticancer Ther; 2005 Aug; 5(4):585-90. PubMed ID: 16111460
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: clinical and economic benefits.
Rader M
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):16-21. PubMed ID: 16736984
[TBL] [Abstract][Full Text] [Related]
17. Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel.
Gridelli C; Aapro MS; Barni S; Beretta GD; Colucci G; Daniele B; Del Mastro L; Di Maio M; De Petris L; Perrone F; Thatcher N; De Marinis F
Crit Rev Oncol Hematol; 2007 Jul; 63(1):53-64. PubMed ID: 17368037
[TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factors in the management of neutropenia and its complications.
Heuser M; Ganser A
Ann Hematol; 2005 Oct; 84(11):697-708. PubMed ID: 16047204
[TBL] [Abstract][Full Text] [Related]
19. Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols.
Dolan S; Crombez P; Munoz M
Eur J Oncol Nurs; 2005; 9 Suppl 1():S14-23. PubMed ID: 16207534
[TBL] [Abstract][Full Text] [Related]
20. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
Timmer-Bonte JN; Tjan-Heijnen VC
Anticancer Drugs; 2006 Sep; 17(8):881-9. PubMed ID: 16940798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]